04.11.2021 • NewsNouryon

Nouryon Expands US Levasil Capacity

Nouryon has announced plans to expand capacity for its Levasil colloidal silica at its site in Green Bay, Wisconsin, USA. The expansion will meet rising demand from North America’s construction and packaging sectors. Construction on the facilityis expected to be completed in the second half of 2022.

Patrick Wilhelm, vice president of inorganic specialties, said large governmental infrastructure projects are fueling the demand growth in construction while e-commerce is driving higher demand for packaging materials.

In construction applications, Levasil products provide durability to structures such as bridges and buildings. They are also used to create anti-slip surfaces in packaging applications, making stacking and handling of finished products easier and more efficient.

Nouryon has eight Levasil production plants around the world. It said expansions were ongoing in Sweden and Taiwan, but did not provide further details.

Author: Elaine Burridge, Freelance Journalist

Nouryon has announced plans to expand capacity for its Levasil colloidal silica...
Nouryon has announced plans to expand capacity for its Levasil colloidal silica at its site in Green Bay, Wisconsin, USA. The expansion will meet rising demand from North America’s construction and packaging sectors. Construction should be completed in H2 2022. (c) Nouryon

Company

Logo:

Nouryon

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.